qi ma
Impact in
- Hepatology top 10%
- Liver physiology and pathology
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Prostate Cancer Diagnosis and Treatment 13
- Prostate Cancer Treatment and Research 9
- Kidney Stones and Urolithiasis Treatments 6
-
- Liver physiology and pathology 7
- Co-authors
- Junfeng Chen (10 shared papers)Zejun Yan (11 shared papers)Ming‐Hai Wang (7 shared papers)Yue Cheng (9 shared papers)Yong-Qing Zhou (5 shared papers)Sunny Guin (5 shared papers)Kejie Wang (13 shared papers)Junhui Jiang (16 shared papers)
- Journals
- Frontiers in Oncology (6 papers)BMC Urology (4 papers)Urolithiasis (3 papers)Molecular Cancer (3 papers)Aging (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
qi ma
95 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 112
- Hepatology 96
- Cancer Research 178
- Pulmonary and Respiratory Medicine 201
- Molecular Biology 397
- Urology 33
Countries citing papers authored by qi ma
This map shows the geographic impact of qi ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by qi ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites qi ma more than expected).
Fields of papers citing papers by qi ma
This network shows the impact of papers produced by qi ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by qi ma. The network helps show where qi ma may publish in the future.
Co-authors
The 25 scholars most cited alongside qi ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 89 | |
| 2 | 2015 | 80 | |
| 3 | 2015 | 63 | |
| 4 | 2021 | 55 | |
| 5 | 2018 | 46 | |
| 6 | 2011 | 44 | |
| 7 | 2011 | 42 | |
| 8 | 2010 | 42 | |
| 9 | 2010 | 30 | |
| 10 | 2019 | 30 | |
| 11 | 2010 | 29 | |
| 12 | 2020 | 28 | |
| 13 | 2017 | 28 | |
| 14 | 2021 | 28 | |
| 15 | 2018 | 28 | |
| 16 | Pinin promotes tumor progression via activating CREB through PI3K/AKT and ERK/MAPK pathway in prostate cancer. | 2021 | 27 |
| 17 | 2020 | 26 | |
| 18 | 2019 | 24 | |
| 19 | 2017 | 23 | |
| 20 | 2024 | 23 |
About qi ma
qi ma is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Cancer Research, Oncology and Surgery, having authored 103 papers that have together received 1.2k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (13 papers), Prostate Cancer Treatment and Research (9 papers), Bladder and Urothelial Cancer Treatments (8 papers), Liver physiology and pathology (7 papers), Kidney Stones and Urolithiasis Treatments (6 papers), Pediatric Urology and Nephrology Studies (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Urinary and Genital Oncology Studies (5 papers). The work is most often cited by research in Hepatology (96 citations), Cancer Research (178 citations), Pulmonary and Respiratory Medicine (201 citations), Molecular Biology (397 citations) and Urology (33 citations) qi ma has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Junfeng Chen, Zejun Yan, Ming‐Hai Wang, Yue Cheng, Yong-Qing Zhou, Sunny Guin, Kejie Wang, Junhui Jiang, Rui Yu and Kaiyun Wang. Their work appears in journals such as Frontiers in Oncology, BMC Urology, Urolithiasis, Molecular Cancer and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.